Subscribe to unlock this article
Thanks for your support.
Okintek Capital, one of the SF which pioneers the Indian market launched by Rehan Netarwala, has just announced the acquisition of the tech-company specialized in intelligent pharmacovigilance Clinevo Technologies. The buyout has been supported by Ambit Partners, Lighthaven, Searchlight ETA (Chaitanya Rathi), Inseta Partners, SFClub, Mazal Capital, The Cromwell Harbor, Spectra Investments, Jasfa (Japan Search Fund Accelerator), Manvendra Saxena, Sumit Garg, Ruiz Family, Zubin Bharti Mittal, Akshat Chaudhary, Nihit Agarwal, and Adit Ravi.
Clinevo Technologies is a technology company specializing in digital solutions for the Life Sciences industry, helping pharmaceutical companies, biotech organizations, and Contract Research Organizations (CROs) optimize clinical trials and pharmacovigilance processes. The company develops cloud-based, regulatory-compliant platforms that support clinical trial management, electronic data capture, patient outcomes, drug safety, and real-time analytics. By leveraging automation, data management, and artificial intelligence, Clinevo enables organizations to improve operational efficiency, reduce costs, and accelerate the development of safer and more effective therapies. The company has more than 200 clients at international level, and has realized more than 1.000 clinical trials.
Legal: ALMT Legal / Tax : Aeka Advisors India / DD: EY / Legal: BakerHostetler
